Christine Hanna
Family Medicine · Bloomfield, CTNPI 1275971905
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 122 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $669, 2.7 times the $252 reported in 2019.
Across 122 payments — averaging $19.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$523
- AstraZeneca$417
- Bayer$406
- Amgen$293
- GSK$132
- Lilly USA, LLC$88
- plus $576 from 16 others
What the payments were for
- Food & beverage$2,434100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 26 | $523 |
| AstraZeneca | 23 | $417 |
| Bayer | 14 | $406 |
| Amgen | 17 | $293 |
| GSK | 7 | $132 |
| Lilly USA, LLC | 5 | $88 |
| AbbVie | 5 | $86 |
| CSL Behring | 3 | $61 |
| Pfizer | 2 | $48 |
| Boehringer Ingelheim | 2 | $46 |
| Astellas Pharma US Inc | 2 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $42 |
| Sanofi-aventis U.S. LLC | 2 | $39 |
| Merck | 2 | $32 |
| Idorsia Pharmaceuticals US Inc | 2 | $29 |
| Abbott | 1 | $25 |
| Mylan Specialty L.p. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Kowa Pharmaceuticals America, Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Novartis | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerendia$129
How this compares
$2,434 in reported general payments places this provider in the 80th percentile of 588 family medicine providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 14 | $291 |
| Atorvastatin Calcium | 19 | $193 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 13 | $166 |
| Escitalopram Oxalate | 16 | $113 |
| Digoxin | 13 | $105 |
| Levothyroxine Sodium | 17 | $84 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Bloomfield
- Rochelle CollinsBloomfield$6K
- Theodore BrunoDurham$201K
- Kenneth DardickStorrs$146K
- Raymond KurkerSouth Windsor$107K
- Thao DoranMarlborough$102K
- Raja FattalehPutnam$53K
- Nicholas TzikasNew Haven$46K
- Helar CamposNew London$29K
- Kristin GianniniVernon$28K
- Sanjeev RaoBridgeport$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.